AtriCure, Inc. provides atrial fibrillation solutions to medical centers in the United States and internationally. The company has market cap of $611.23 million. The firm offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures, such as coronary artery bypass grafting and/or valve replacement or repair; COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy; and EPi-Sense guided coagulation system used for the temporary cardiac signal sensing and recording during surgery. It currently has negative earnings. It also provides SUBTLE cannula, an access device and conduit for the ablation device and endoscope to enable a closed chest endoscopic approach; multifunctional pens that allow surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and linear ablation devices, which enable physicians to create an expanded cardiac ablation lesion set.
Ray Gerald L & Associates Ltd decreased Monsanto Co New (MON) stake by 22.99% reported in 2017Q3 SEC filing. Ray Gerald L & Associates Ltd sold 3,350 shares as Monsanto Co New (MON)’s stock rose 6.51%. The Ray Gerald L & Associates Ltd holds 11,224 shares with $1.35M value, down from 14,574 last quarter. Monsanto Co New now has $52.76 billion valuation. The stock increased 0.13% or $0.16 during the last trading session, reaching $119.7. About 2.20 million shares traded. Monsanto Company (NYSE:MON) has risen 15.46% since January 14, 2017 and is uptrending. It has underperformed by 1.24% the S&P500.
Ray Gerald L & Associates Ltd increased Western Digital Corp (NASDAQ:WDC) stake by 6,081 shares to 20,151 valued at $1.74M in 2017Q3. It also upped Bancfirst Corp (NASDAQ:BANF) stake by 6,000 shares and now owns 12,000 shares. Vanguard Tax Managed Intl Fd (VEA) was raised too.
Investors sentiment decreased to 0.84 in Q3 2017. Its down 0.14, from 0.98 in 2017Q2. It dropped, as 48 investors sold MON shares while 342 reduced holdings. 84 funds opened positions while 244 raised stakes. 321.42 million shares or 4.04% more from 308.94 million shares in 2017Q2 were reported. Aqr Capital Management Ltd Company owns 498,366 shares or 0.07% of their US portfolio. Daiwa Secs Grp Inc invested in 0.01% or 13,174 shares. Shine Advisory Service reported 0.01% stake. The New York-based Loeb Corp has invested 0.73% in Monsanto Company (NYSE:MON). Aspiriant Limited Liability Company reported 7,180 shares. Highstreet Asset Mngmt Inc accumulated 3,422 shares or 0.04% of the stock. Commerzbank Aktiengesellschaft Fi reported 42,980 shares. The United Kingdom-based Pictet Asset Mngmt has invested 0.2% in Monsanto Company (NYSE:MON). 28.11M were accumulated by Blackrock. Rocky Mountain Advisers Ltd has invested 0.01% in Monsanto Company (NYSE:MON). Tiedemann Wealth Lc holds 0.04% or 2,724 shares in its portfolio. Tortoise Investment Ltd Liability accumulated 0.01% or 335 shares. Country Tru Bank owns 218,673 shares for 1.19% of their portfolio. Marshall Wace Llp accumulated 444,949 shares. Transamerica Incorporated holds 1 shares or 0% of its portfolio.
Since September 25, 2017, it had 0 insider purchases, and 6 insider sales for $6.90 million activity. The insider Courduroux Pierre sold 4,320 shares worth $527,040. Another trade for 22,640 shares valued at $2.72 million was sold by BEGEMANN BRETT D. 2,860 shares were sold by Narain Duraiswami, worth $343,200. 7,890 shares were sold by Ringenberg Nicole M, worth $964,553. On Monday, October 9 MIZELL STEVEN sold $1.38 million worth of Monsanto Company (NYSE:MON) or 11,526 shares.
Among 23 analysts covering Monsanto Company (NYSE:MON), 12 have Buy rating, 0 Sell and 11 Hold. Therefore 52% are positive. Monsanto Company had 60 analyst reports since August 25, 2015 according to SRatingsIntel. The stock has “Hold” rating by Jefferies on Monday, August 14. On Wednesday, June 28 the stock rating was maintained by BMO Capital Markets with “Buy”. CLSA upgraded the shares of MON in report on Friday, January 6 to “Outperform” rating. The stock of Monsanto Company (NYSE:MON) has “Hold” rating given on Monday, March 14 by Citigroup. The firm earned “Sector Perform” rating on Thursday, February 23 by RBC Capital Markets. The firm has “Buy” rating given on Thursday, September 15 by Deutsche Bank. The firm has “Neutral” rating by Goldman Sachs given on Wednesday, September 23. As per Thursday, August 27, the company rating was maintained by Canaccord Genuity. RBC Capital Markets maintained it with “Hold” rating and $128.0 target in Monday, November 13 report. The stock has “Sell” rating by Goldman Sachs on Monday, April 11.
Since January 1, 0001, it had 0 insider buys, and 1 sale for $224,000 activity.
The stock increased 0.23% or $0.04 during the last trading session, reaching $17.73. About 152,238 shares traded. AtriCure, Inc. (ATRC) has risen 53.35% since January 14, 2017 and is uptrending. It has outperformed by 36.65% the S&P500.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.